Trial Profile
A Phase III study of IZN-101 in rheumatoid arthritis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2020
Price :
$35
*
At a glance
- Drugs Namilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Apr 2020 New trial record